West Family Investments Inc. Makes New $285,000 Investment in Humana Inc. (NYSE:HUM)

West Family Investments Inc. acquired a new stake in shares of Humana Inc. (NYSE:HUM) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 623 shares of the insurance provider’s stock, valued at approximately $285,000.

Several other hedge funds and other institutional investors have also recently modified their holdings of the stock. Auxano Advisors LLC purchased a new stake in Humana during the 4th quarter valued at about $540,000. Mariner LLC increased its holdings in Humana by 2.3% in the 3rd quarter. Mariner LLC now owns 14,119 shares of the insurance provider’s stock worth $6,869,000 after buying an additional 312 shares during the period. Massachusetts Financial Services Co. MA raised its position in Humana by 27.5% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 27,943 shares of the insurance provider’s stock worth $13,595,000 after buying an additional 6,034 shares during the last quarter. Silverarc Capital Management LLC acquired a new stake in Humana during the 3rd quarter valued at approximately $4,865,000. Finally, Vest Financial LLC boosted its holdings in shares of Humana by 43.3% in the 4th quarter. Vest Financial LLC now owns 27,993 shares of the insurance provider’s stock valued at $12,815,000 after acquiring an additional 8,455 shares during the last quarter. 92.38% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

HUM has been the topic of several analyst reports. TheStreet downgraded Humana from a “b” rating to a “c+” rating in a research report on Monday, January 8th. Mizuho decreased their price target on Humana from $550.00 to $400.00 and set a “buy” rating for the company in a report on Friday, January 26th. Argus lowered shares of Humana from a “buy” rating to a “hold” rating in a report on Wednesday, March 13th. Bank of America reissued a “neutral” rating and set a $342.00 price target (down from $470.00) on shares of Humana in a report on Tuesday, April 2nd. Finally, Truist Financial reiterated a “hold” rating and issued a $550.00 price objective on shares of Humana in a research report on Friday, January 19th. Eleven equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $424.50.

Insider Transactions at Humana

In related news, Director Jorge S. Mesquita purchased 545 shares of Humana stock in a transaction on Tuesday, February 20th. The shares were bought at an average price of $367.09 per share, with a total value of $200,064.05. Following the transaction, the director now directly owns 2,578 shares of the company’s stock, valued at $946,358.02. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 0.32% of the company’s stock.

Humana Trading Up 2.0 %

Humana stock traded up $6.20 during trading on Thursday, hitting $320.41. The company had a trading volume of 626,693 shares, compared to its average volume of 1,981,064. Humana Inc. has a 1-year low of $298.61 and a 1-year high of $541.21. The company has a current ratio of 1.67, a quick ratio of 1.67 and a debt-to-equity ratio of 0.77. The company’s 50 day simple moving average is $325.28 and its 200-day simple moving average is $390.72. The stock has a market cap of $38.61 billion, a price-to-earnings ratio of 19.94, a price-to-earnings-growth ratio of 1.76 and a beta of 0.50.

Humana (NYSE:HUM) last announced its earnings results on Wednesday, April 24th. The insurance provider reported $7.23 EPS for the quarter, beating analysts’ consensus estimates of $6.12 by $1.11. The company had revenue of $29.61 billion during the quarter, compared to analysts’ expectations of $28.52 billion. Humana had a return on equity of 17.76% and a net margin of 1.82%. Humana’s revenue for the quarter was up 10.7% on a year-over-year basis. During the same period last year, the business posted $9.38 EPS. As a group, analysts expect that Humana Inc. will post 16.18 EPS for the current fiscal year.

Humana Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 26th. Shareholders of record on Friday, June 28th will be paid a $0.885 dividend. The ex-dividend date is Friday, June 28th. This represents a $3.54 annualized dividend and a dividend yield of 1.10%. Humana’s dividend payout ratio (DPR) is 22.04%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.